1. Home
  2. CIG vs CYTK Comparison

CIG vs CYTK Comparison

Compare CIG & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIG
  • CYTK
  • Stock Information
  • Founded
  • CIG 1952
  • CYTK 1997
  • Country
  • CIG Brazil
  • CYTK United States
  • Employees
  • CIG N/A
  • CYTK N/A
  • Industry
  • CIG Electric Utilities: Central
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIG Utilities
  • CYTK Health Care
  • Exchange
  • CIG Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • CIG 5.5B
  • CYTK 4.4B
  • IPO Year
  • CIG N/A
  • CYTK 2004
  • Fundamental
  • Price
  • CIG $1.98
  • CYTK $38.34
  • Analyst Decision
  • CIG
  • CYTK Buy
  • Analyst Count
  • CIG 0
  • CYTK 13
  • Target Price
  • CIG N/A
  • CYTK $71.58
  • AVG Volume (30 Days)
  • CIG 2.4M
  • CYTK 1.5M
  • Earning Date
  • CIG 08-14-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • CIG 15.19%
  • CYTK N/A
  • EPS Growth
  • CIG N/A
  • CYTK N/A
  • EPS
  • CIG 0.42
  • CYTK N/A
  • Revenue
  • CIG $7,700,096,899.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • CIG N/A
  • CYTK $330.96
  • Revenue Next Year
  • CIG N/A
  • CYTK $73.41
  • P/E Ratio
  • CIG $5.42
  • CYTK N/A
  • Revenue Growth
  • CIG 10.77
  • CYTK 2635.74
  • 52 Week Low
  • CIG $1.59
  • CYTK $29.31
  • 52 Week High
  • CIG $2.19
  • CYTK $59.39
  • Technical
  • Relative Strength Index (RSI)
  • CIG 58.79
  • CYTK 57.94
  • Support Level
  • CIG $1.90
  • CYTK $36.77
  • Resistance Level
  • CIG $1.97
  • CYTK $39.45
  • Average True Range (ATR)
  • CIG 0.04
  • CYTK 1.69
  • MACD
  • CIG 0.01
  • CYTK 0.19
  • Stochastic Oscillator
  • CIG 90.00
  • CYTK 83.08

About CIG Comp En De Mn Cemig ADS

Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: